123 related articles for article (PubMed ID: 36028955)
1. Bone disease in patients with cirrhosis of different etiology and severity; are Klotho protein and osteoprotegerin potential biomarkers?
Katsaounis PV; Hadjiyannis ES; Skaltsi T; Anargyrou VA; Alexopoulou AA; Dourakis SP; Koskinas JS
Scand J Gastroenterol; 2023 Feb; 58(2):185-192. PubMed ID: 36028955
[TBL] [Abstract][Full Text] [Related]
2. The RANKL/OPG system and bone mineral density in patients with chronic liver disease.
Moschen AR; Kaser A; Stadlmann S; Millonig G; Kaser S; Mühllechner P; Habior A; Graziadei I; Vogel W; Tilg H
J Hepatol; 2005 Dec; 43(6):973-83. PubMed ID: 16143421
[TBL] [Abstract][Full Text] [Related]
3. Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease.
Monegal A; Navasa M; Peris P; Alvarez L; Pons F; Rodés J; Guañabens N
Liver Int; 2007 May; 27(4):492-7. PubMed ID: 17403189
[TBL] [Abstract][Full Text] [Related]
4. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation.
Monegal A; Navasa M; Guañabens N; Peris P; Pons F; Martinez de Osaba MJ; Rimola A; Rodés J; Muñoz-Gómez J
Calcif Tissue Int; 1997 Feb; 60(2):148-54. PubMed ID: 9056162
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density loss in patients with cirrhosis.
Muhsen IN; AlFreihi O; Abaalkhail F; AlKhenizan A; Khan M; Eldali A; Alsohaibani F
Saudi J Gastroenterol; 2018; 24(6):342-347. PubMed ID: 29943736
[TBL] [Abstract][Full Text] [Related]
6. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
[TBL] [Abstract][Full Text] [Related]
7. Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients.
Zheng S; Chen Y; Zheng Y; Zhou Z; Li Z
Eur J Med Res; 2018 Apr; 23(1):18. PubMed ID: 29665846
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and characteristics of bone disease in cirrhotic patients under evaluation for liver transplantation.
Alcalde Vargas A; Pascasio Acevedo JM; Gutiérrez Domingo I; García Jiménez R; Sousa Martín JM; Ferrer Ríos MT; Sayago Mota M; Giráldez Gallego A; Gómez Bravo MA
Transplant Proc; 2012; 44(6):1496-8. PubMed ID: 22841194
[TBL] [Abstract][Full Text] [Related]
9. Serum Osteoprotegerin Level Is Negatively Associated with Bone Mineral Density in Patients Undergoing Maintenance Hemodialysis.
Lu CW; Wang CH; Hsu BG; Tsai JP
Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440966
[TBL] [Abstract][Full Text] [Related]
10. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis.
Xu S; Wang Y; Lu J; Xu J
Rheumatol Int; 2012 Nov; 32(11):3397-403. PubMed ID: 22057136
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density and serum levels of soluble tumor necrosis factors, estradiol, and osteoprotegerin in postmenopausal women with cirrhosis after viral hepatitis.
González-Calvin JL; Mundi JL; Casado-Caballero FJ; Abadia AC; Martin-Ibañez JJ
J Clin Endocrinol Metab; 2009 Dec; 94(12):4844-50. PubMed ID: 19897681
[TBL] [Abstract][Full Text] [Related]
12. RISK FACTORS ASSOCIATED WITH FRACTURE OF THE LUMBOSACRAL SPINE AND ITS COMPROMISE IN THE QUALITY OF LIFE OF CIRRHOTICS.
Siqueira MMLG; Casulari LA; Freitas WM; Carneiro MV; Mendes LSC
Arq Gastroenterol; 2022; 59(1):9-15. PubMed ID: 35442344
[TBL] [Abstract][Full Text] [Related]
13. [Osteoprotegerin and bone mineral density in patients with chronic obstructive pulmonary disease].
Kochetkova EA; Nevzorova VA; Maĭstrovskaia IuV; Massard G
Ter Arkh; 2010; 82(8):10-4. PubMed ID: 20873238
[TBL] [Abstract][Full Text] [Related]
14. Determinants of bone mineral density in stable kidney transplant recipients.
Gupta AK; Huang M; Prasad GV
J Nephrol; 2012; 25(3):373-83. PubMed ID: 21928224
[TBL] [Abstract][Full Text] [Related]
15. Study of Correlation of Bone Mineral Density with Severity of Liver Cirrhosis.
Shukla V; Fatima J; Siddiqui Z; Kugashiya R; Islam ZU
J Assoc Physicians India; 2023 Jun; 71(6):11-12. PubMed ID: 37355840
[TBL] [Abstract][Full Text] [Related]
16. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for osteoporosis in liver cirrhosis patients measured by transient elastography.
Zheng JP; Miao HX; Zheng SW; Liu WL; Chen CQ; Zhong HB; Li SF; Fang YP; Sun CH
Medicine (Baltimore); 2018 May; 97(20):e10645. PubMed ID: 29768330
[TBL] [Abstract][Full Text] [Related]
18. Inverse Association Between Serum Osteoprotegerin and Bone Mineral Density in Renal Transplant Recipients.
Hsu BG; Chen YC; Ho GJ; Shih MH; Chou KC; Lin TY; Lee MC
Transplant Proc; 2016 Apr; 48(3):864-9. PubMed ID: 27234754
[TBL] [Abstract][Full Text] [Related]
19. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
20. Osteoprotegerin and bone mineral density in hemodiafiltration patients.
Crisafulli A; Romeo A; Floccari F; Aloisi E; Atteritano M; Cincotta M; Aloisi C; Pizzoleo MA; Ruello A; Artemisia A; Valenti A; Frisina N; Teti D; Buemi M
Ren Fail; 2005; 27(5):531-9. PubMed ID: 16152990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
